Search
for
Sort by
Research 421–450 of 1000+
- Clinical profile of androgenic alopecia and its association with cardiovascular risk factors
- Treatment of Androgenetic Alopecia Using PRP to Target Dysregulated Mechanisms and Pathways
- Androgenetic alopecia: An update
- Keratinocyte Growth Inhibition through the Modification of Wnt Signaling by Androgen in Balding Dermal Papilla Cells
- Androgenetic alopecia and coronary artery disease in women
- Cause of Androgenic Alopecia
- Health-Related Quality of Life, Depression, and Self-esteem in Patients With Androgenetic Alopecia
- Are 2D:4D finger-length ratios an indicator of androgenetic alopecia in males?
- Efficacy of finasteride for treating patients with androgenetic alopecia who are pileous in other areas: A pilot study in Japan
- Impaired metabolic effects of metformin in men with early-onset androgenic alopecia
- The AR/miR-221/IGF-1 pathway mediates the pathogenesis of androgenetic alopecia
- An Herbal Extract Combination (Biochanin A, Acetyl tetrapeptide-3, and Ginseng Extracts) versus 3% Minoxidil Solution for the Treatment of Androgenetic Alopecia: A 24-week, Prospective, Randomized, Triple-blind, Controlled Trial
- Androgenic alopecia, premature graying, and hair thinning as independent predictors of coronary artery disease in young Asian males
- Evaluation of Hair Follicle Counts of Occipital Scalp Biopsies from Male Hair Transplant Patients in Thailand
- Sex differences in clinical trials of ALRV5XR treatment of androgenetic alopecia and telogen effluvium
- The state‐of‐the‐art in the management of androgenetic alopecia: A review of new therapies and treatment algorithms
- Epidemiology and disease burden of androgenetic alopecia in college freshmen in China: A population-based study
- Platelet-rich plasma in androgenetic alopecia
- Role of serum androgens and prostate-specific antigen levels in men with androgenetic alopecia
- Androgenic Alopecia: Cross-Talk Between Cell Signal Transduction Pathways
- PCA: A tFNA-based targeted nucleic acid nanocomposite hydrogel for the treatment of androgenetic alopecia through the promotion of angiogenesis and hair follicle stem cell proliferation
- Long‐Term Efficacy and Safety of Low‐Level Laser Therapy for Androgenetic Alopecia: A 12‐Month Prospective Trial
- Biomedical Technologies for Androgenic Alopecia Treatment: Advance, Mechanism and Future Direction
- Efficacy and safety of topical GT20029 in male patients with androgenetic alopecia: a multicenter, randomized, double-blind, placebo-controlled phase 2 study
- Impact of a Novel Dietary Supplement on Efficacy of Pharmacological Treatments for Androgenic Alopecia: A Real‐Life, Multicenter, Randomized, Assessor‐Blinded Trial on 225 Subjects
- [Artículo traducido] Comparación entre la aplicación subcutánea vs. subcutánea e intramuscular combinada de toxina botulínica para el tratamiento de la alopecia androgenética: un ensayo clínico aleatorizado
- Comparative Study of a Topical and Oral Combination Therapy Containing Oleanolic Acid, Apigenin, and Biotinyl Tripeptide-1 in Patients with Androgenetic Alopecia: A Prospective, Open-Label Trial
- Effects of Platelet-Rich Plasma on Hair Growth using Artificial Intelligence-based Trichoscopy and Ki67+ Keratinocytes Analysis: A Randomized Placebo-Controlled Trial
- Potential Causal Relationship Between Extensive Lipid Profiles and Various Hair Loss Diseases: Evidence From Univariable and Multivariable Mendelian Randomization Analyses
- Efficacy of Oral Supplementation with Serenoa Repens, Pumpkin Seed Extract and Cysteine Combined with Topical Minoxidil 5% Vs Topical Minoxidil 5% Alone in Androgenic Alopecia A Randomised Assessor-Blinded 6-Month, Superiority Trial